| Name: | Clozapine EP Impurity B |
| Catalogue No. | VL1310002 |
| CAS No. | 263366-81-0 |
| Molecular Formula | C30H24Cl2N6 |
| Molecular Weight | 539.6 |
| Status | In-stock |
| IUPAC Name | 1,4-bis(8-chloro-5H-dibenzo[b,e][1,4]diazepin-11-yl)piperazine |
| Synonyms | Clozapine BP Impurity B |
| Appearance | Off White powder |
| Description | Clozapine EP Impurity B (CAS No.: 263366-81-0) or Clozapine BP Impurity B is a metabolite of Clozapine. Clozapine is an atypical antipsychotic agent. Its mechanism of action is believed to be related to its reaction with dopamine and serotonin (5-HT) neurotransmitter systems. |
| References | Aravagiri, M., and S. R. Marder. “Simultaneous Determination of Clozapine and Its N-Desmethyl and N-Oxide Metabolites in Plasma by Liquid Chromatography/Electrospray Tandem Mass Spectrometry and Its Application to Plasma Level Monitoring in Schizophrenic Patients.” Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 2, Sept. 2001, pp. 301–11,https://doi.org/10.1016/s0731-7085(01)00410-1. Wagstaff, Antona J., and Harriet M. Bryson. “Clozapine.” CNS Drugs, vol. 4, no. 5, Nov. 1995, pp |
![2,8-Dichloro-6,12-diphenyldibenzo[b,f][1,5]diazocine](/public/site/files/site_images/thumb_2-8-dichloro-6-12-diphenyldibenzo-b-f-1-5-diazocine23368.png)